Bicycle Therapeutics plc — Key Metrics
3 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Expense Ratios
Working Capital Analysis
Valuation Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
EPS (Diluted)
$-3
Book Value Per Share
$9
Free Cash Flow Per Share
$-4
Cash Per Share
$9
Revenue Per Share
$1
OCF Per Share
$-4
Return on Equity
-31.2%
Return on Assets
-26.2%
Return on Invested Capital
-27.8%
Debt to Equity
0.08
Current Ratio
11.98
Quick Ratio
11.98
Asset Turnover
0.09
Days Sales Outstanding
0.00
R&D / Revenue
331.0%
SBC / Revenue
54.4%
Capex / Revenue
3.2%
Working Capital
$626M
Net Current Asset Value
$575M
Invested Capital
$610M
OCF / Net Income
1.14
FCF / Net Income
1.15
Accruals Ratio (Sloan)
4.3%
Net Debt
$-628M
Net Debt / EBITDA
2.61
Interest Coverage
-1199.34
Cash Coverage
-1212.01
Capex Coverage
-106.24
Tangible Common Equity
$610M
TCE / Total Assets
85.0%
NOPAT
$-195M
Cash ROIC
-35.9%
WC / Revenue
862.3%
Capex / D&A
0.37
Reinvestment Rate
1.6%
Asset Growth vs Revenue Growth
-130.8%
Revenue 5Y CAGR
47.5%
Book Value 5Y CAGR
44.9%
Stock Price (FY-end)
$7
Market Cap
$491M
P/S Ratio
6.76
P/B Ratio
0.80
P/TB Ratio
0.80
Enterprise Value
$-138M
EV / Sales
-1.90
FCF Yield
-51.4%
Shareholder Yield
-8.0%
R&D Yield
49.0%
Capex Yield
0.5%
Shares Variation (YoY)
19.0%
Beta (5Y)
1.08
Cost of Equity
9.9%
Cost of Debt (after tax)
8.4%
52W High
$15
52W Low
$6
Trailing Return 1Y
-51.3%
Trailing Return 5Y
-64.2%
F-Score (Piotroski)
1.00
Z-Score (Altman)
0.99
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.